A Val227 ala polymorphism in the peroxisome proliferator activated receptor α (PPARα) gene is associated with variations in serum lipid levels [2]

Journal of Medical Genetics

Volumn 39, Issue 3, 2002, Pages 189-191

  Yamakawa Kobayashi, K ^a   Ishiguro, H ^a   Arinami, T ^a   Miyazaki, R ^a   Hamaguchi, H ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GENE PRODUCT; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; VALINE; CELL RECEPTOR; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ADULT; AGED; CONTROLLED STUDY; DIMERIZATION; DNA SEQUENCE; FEMALE; GENE CONTROL; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOME; HUMAN; LETTER; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR BINDING; AGING; ASIAN; BLOOD; BODY MASS; CHEMISTRY; DIET RESTRICTION; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; JAPAN; MIDDLE AGED; MISSENSE MUTATION; SEXUAL DEVELOPMENT;

ADULT; AGED; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; FASTING; FEMALE; GENOTYPE; HUMANS; JAPAN; LIPIDS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEX CHARACTERISTICS; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0036009175     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (24)

1. Roles of PPARs in health and disease
2. Peroxisome proliferator-activated receptors: Insight into multiple cellular functions
3. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
4. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat
5. Differential expression of peroxisome proliferator-activated PPAR-α, -β, and -γ during rat embryonic development
6. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
7. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation
8. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
9. Mechanism of action of fibrates on lipid and lipoprotein metabolism
10. Targeted disruption of the α-isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
11. Peroxisome proliferator-activated receptors, orphans with ligands and functions
12. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging
13. Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects
14. Molecular scanning of the human PPARα gene: Association of the L162V mutation with hyperapobetalipoproteinemia
15. Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene
16. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge
17. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
18. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor α-deficient mice
19. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements
20. The human peroxisome proliferator-activated receptor α gene: Identification and functional characterization of two natural allelic variants
21. An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk
22. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: A review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes meltitus
23. Genetics of lipoprotein abnormalities associated with coronary heart disease susceptibility
24. Apolipoprotein E in hyperlipidemia